Lixin Rui
653
page-template,page-template-full_width,page-template-full_width-php,page,page-id-653,page-child,parent-pageid-320,bridge-core-3.0.2,,vertical_menu_enabled,qode-title-hidden,qode_grid_1300,side_area_uncovered_from_content,qode-theme-ver-28.8,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.9.0,vc_responsive
Rui

Discovery Spotlight

Lixin Rui, PhD

 

Associate Professor
Department of Medicine

 

Cellular signaling and epigenetic mechanisms in B cell lymphoma

The major research focus of Dr. Rui’s laboratory is on mechanisms of B-cell receptor and JAK-STAT signaling pathways and epigenetic enzymes, including protein arginine methyltransferase 5 (PRMT5) and DNA methyltransferases (DNMTs), in lymphomagenesis. His research team employs a multidisciplinary approach, using biochemistry, RNA interference, genomic technologies, CRISPR/Cas9 and systems biology methods, to identify mechanisms downstream of the B-cell receptor and JAK-STAT signaling pathways and establish the function of these epigenetic enzymes in B cell lymphoma. The goal of his research is to discover molecular targets in these pathways for therapeutic, diagnostic and prognostic development of B cell lymphoma.

 

Publications:
https://www.ncbi.nlm.nih.gov/myncbi/12CH-2wLplkAf/bibliography/public/